Effect of a Medication Reminder Mobile Application

NCT06477068 | Completed DMC

• 1 other identifier: CS/HV/23/29
• Study Type: interventional
• Target: 387
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical trial is to evaluate of effectiveness when using the "telemedicine medication reminder app on smartphones" at the Infertility Department of Hung Vuong Hospital. The main questions it aims to answer are: Comparison of the medication forgetting rate between the group of patients using the product and the group of patients not using the app. Assessment of the level of patient satisfaction when using the app. Comparison of the quantity and quality outcomes of eggs between the group of patients using the app and the group of patients not using the app. Participants will: Using or not using " "telemedicine medication reminder app on smartphones" Record the number of cycle cancellations, number of missed doses, satisfaction rates, number of retrieved oocytes, number of mature oocytes, number of immature oocytes, and number of abnormal oocytes.

Conditions

Infertility

Outcome Measures

Primary Outcomes (2)

• Medication non-adherence rate

  Comparison of the medication non-adherence rate (in percentage) between the group of IVF patients using the mobile medical reminder application and the group of IVF patients not using the mobile medical reminder application. The medication non-adherence rate is calculated as the number of times the medication was forgotten divided by the total number of prescribed medication doses. Unit of measure: Percentage (%)

  6 months

• Grading on Mobile Application Rating Scale

  Assessment of the mobile medical reminder application quality will be graded following the Mobile Application Rating Scale (MARS). MARS includes a set of questions that are graded by users. Users will rate the app on a scale from 1 to 5. The average MARS score will be used. Unit of measure: Quality score (MARS)

  6 months

Secondary Outcomes (3)

• Total retrieved oocytes

  6 months

• Total mature oocytes

  6 month

• Total abnormal oocytes

  6 month

Study Arms (1)

IVF Patients

EXPERIMENTAL

Patients undergoes ovarian stimulation for IVF treatment at Hung Vuong Hospital

Combination Product: Mobile medical reminder application

Interventions

Mobile medical reminder application COMBINATION_PRODUCT

Experimental group: Patients undergoing ovarian stimulation in the Infertility Department at Hung Vuong Hospital are prescribed and instructed to inject medication according to the current procedure of the department, in addition to being supported through the "telemedicine medication reminder app on smartphones". Control group: Patients undergoing ovarian stimulation in the Infertility Department at Hung Vuong Hospital are prescribed and instructed to inject medication according to the current procedure of the department.

IVF Patients

Eligibility Criteria

• Age: 18 Years - 40 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• To eliminate factors that may affect egg quality, we selected patients with good prognosis for the study (18-\< 40 years old, undergoing IVF treatment for the first time).
• Indicated for ovarian stimulation for IVF treatment.
• Be able to use a smartphone.
• No underlying diseases: Diabetes mellitus, Increased prolactin, Thyroid dysfunction, and Adrenal disorders.
• Voluntary participate in the study and agree to sign the consent form.

You may not qualify if:

• BMI \> 30.
• IVF patient with oocyte donation.
• Reduced ovarian reserve.
• Contraindications for using ovarian stimulation drugs.
• Endocrine or metabolic disorders, any underlying diseases (kidney, liver, or heart disease).
• Subjects unwilling to participate in the study.
• Patients who are unable to comply with the study protocol: not using a smartphone, missing appointments for follow-up visits, unable to read or write in Vietnamese.

Sponsors & Collaborators

• Hung Vuong Hospital: lead

Study Sites (1)

Hung Vuong

Ho Chi Minh City, 70000, Vietnam

Location

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital Diseases; Urogenital Diseases

Study Officials

• Le-Giang Tran, Ph.D.

  International University, Vietnam National University - Hochiminh City

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Hung Vuong Hospital

Model Details: Experimental group: Patients undergoing ovarian stimulation in the Infertility Department at Hung Vuong Hospital are prescribed and instructed to inject medication according to the current procedure of the department, in addition to being supported through the "telemedicine medication reminder app on smartphones". Control group: Patients undergoing ovarian stimulation in the Infertility Department at Hung Vuong Hospital are prescribed and instructed to inject medication according to the current procedure of the department.

Study Record Dates

• First Submitted: May 25, 2024
• First Posted: June 27, 2024
• Study Start: May 22, 2024
• Primary Completion: March 9, 2026
• Study Completion: April 22, 2026
• Last Updated: April 29, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share

Locations

VN (1)